| Purpose | Patients | Evaluations | Perceived Effectiveness |
|---|---|---|---|
| Diagnostic assessment | 6 | 1 | |
| Lupus nephritis | 5 | 1 | |
| Glomerulonephritis | 3 | 0 | |
| Alport syndrome | 1 | 0 | |
| Multiple myeloma | 1 | 0 |
Side effect severity
| Severity | Evaluations | Percentage |
|---|---|---|
| Severe | 0 | |
| Moderate | 0 | |
| Mild | 1 | |
| None | 1 |
| Purpose | Patients | Evaluations | Perceived Effectiveness |
|---|---|---|---|
| Diagnostic assessment | 6 | 1 | |
| Lupus nephritis | 5 | 1 | |
| Glomerulonephritis | 3 | 0 | |
| Alport syndrome | 1 | 0 | |
| Multiple myeloma | 1 | 0 |
| Severity | Evaluations | Percentage |
|---|---|---|
| Severe | 0 | |
| Moderate | 0 | |
| Mild | 1 | |
| None | 1 |